CHIARADONNA, FERDINANDO
 Distribuzione geografica
Continente #
NA - Nord America 6.926
EU - Europa 4.600
AS - Asia 3.407
SA - Sud America 536
AF - Africa 62
OC - Oceania 10
Continente sconosciuto - Info sul continente non disponibili 5
Totale 15.546
Nazione #
US - Stati Uniti d'America 6.726
IT - Italia 1.381
SG - Singapore 1.250
CN - Cina 982
DE - Germania 684
RU - Federazione Russa 548
BR - Brasile 439
HK - Hong Kong 435
PL - Polonia 336
SE - Svezia 333
VN - Vietnam 292
IE - Irlanda 282
GB - Regno Unito 228
FR - Francia 163
UA - Ucraina 160
CA - Canada 151
FI - Finlandia 136
IN - India 97
NL - Olanda 84
AT - Austria 72
ID - Indonesia 69
DK - Danimarca 63
TR - Turchia 63
KR - Corea 62
AR - Argentina 45
MX - Messico 38
ZA - Sudafrica 31
BE - Belgio 29
JP - Giappone 29
BD - Bangladesh 26
CH - Svizzera 25
ES - Italia 21
IR - Iran 20
IQ - Iraq 16
CZ - Repubblica Ceca 15
EC - Ecuador 15
PY - Paraguay 9
CL - Cile 8
PK - Pakistan 8
UZ - Uzbekistan 8
AE - Emirati Arabi Uniti 7
CO - Colombia 7
LU - Lussemburgo 7
TN - Tunisia 7
VE - Venezuela 7
AU - Australia 6
EG - Egitto 6
LT - Lituania 6
GR - Grecia 5
PA - Panama 5
TW - Taiwan 5
AL - Albania 4
KG - Kirghizistan 4
MA - Marocco 4
MY - Malesia 4
NZ - Nuova Zelanda 4
PH - Filippine 4
SK - Slovacchia (Repubblica Slovacca) 4
AZ - Azerbaigian 3
DZ - Algeria 3
EU - Europa 3
HU - Ungheria 3
KE - Kenya 3
NO - Norvegia 3
NP - Nepal 3
PE - Perù 3
RO - Romania 3
SA - Arabia Saudita 3
SN - Senegal 3
UY - Uruguay 3
BH - Bahrain 2
CI - Costa d'Avorio 2
DO - Repubblica Dominicana 2
ET - Etiopia 2
IL - Israele 2
JM - Giamaica 2
JO - Giordania 2
PS - Palestinian Territory 2
PT - Portogallo 2
A1 - Anonimo 1
BG - Bulgaria 1
BS - Bahamas 1
DM - Dominica 1
GE - Georgia 1
HR - Croazia 1
KH - Cambogia 1
KW - Kuwait 1
KZ - Kazakistan 1
LB - Libano 1
LK - Sri Lanka 1
LV - Lettonia 1
MN - Mongolia 1
QA - Qatar 1
SC - Seychelles 1
SY - Repubblica araba siriana 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 15.546
Città #
Ann Arbor 1.229
Singapore 765
Ashburn 635
Woodbridge 501
Milan 432
Hong Kong 430
Fairfield 404
Frankfurt am Main 343
Wilmington 342
Chandler 336
Houston 291
Kraków 280
Dublin 274
Dallas 234
Beijing 184
New York 170
Jacksonville 168
Dearborn 167
Hefei 159
Seattle 159
Santa Clara 147
Cambridge 146
Los Angeles 133
Munich 132
Princeton 84
Ho Chi Minh City 78
The Dalles 73
Buffalo 68
Helsinki 66
Nanjing 62
Jakarta 61
Seoul 59
Shanghai 58
Hanoi 52
Moscow 52
Dong Ket 49
Vienna 49
São Paulo 48
Lawrence 42
Guangzhou 40
Warsaw 39
Montréal 38
Chicago 37
Rome 37
San Diego 36
Toronto 34
Boardman 33
Altamura 32
Cento 32
Council Bluffs 32
Brussels 28
Lachine 28
Denver 26
Atlanta 25
Nanchang 25
Nuremberg 25
Johannesburg 23
Poplar 21
Tianjin 21
Chennai 20
Orem 20
Tokyo 20
Torino 20
Bologna 19
Montreal 19
Zhengzhou 19
Andover 18
Ankara 18
Brooklyn 18
Falls Church 18
London 17
Salt Lake City 17
Turin 17
Kent 16
Naples 16
Rio de Janeiro 15
Amsterdam 14
Brusuglio 14
Kunming 14
Hebei 13
Huizen 13
Paris 13
Sacramento 13
Stockholm 13
Hyderabad 12
Shenyang 12
Turku 12
Bergamo 11
Lappeenranta 11
Manchester 11
Phoenix 11
Querétaro 11
Tampa 11
Verona 11
Brescia 10
Columbus 10
Jiaxing 10
Monza 10
Mumbai 10
Ningbo 10
Totale 10.161
Nome #
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition) 625
Inhibition of the Hexosamine Biosynthetic Pathway by targeting PGM3 causes breast cancer growth arrest and apoptosis 620
Fuzzy modeling and global optimization to predict novel therapeutic targets in cancer cells 475
Design, Synthesis, and Preliminary Biological Evaluation of GlcNAc-6P Analogues for the Modulation of Phosphoacetylglucosamine Mutase 1 (AGM1/PGM3) 450
The Nutrient-Sensing Hexosamine Biosynthetic Pathway as the Hub of Cancer Metabolic Rewiring. 411
Protein Kinase A Activation Promotes Cancer Cell Resistance to Glucose Starvation and Anoikis 405
Hexosamine pathway inhibition overcomes pancreatic cancer resistance to gemcitabine through unfolded protein response and EGFR-Akt pathway modulation 378
Central metabolism of functionally heterogeneous mesenchymal stromal cells 358
From cancer metabolism to new biomarkers and drug targets 351
Analysis of mitochondrial metabolism in situ: Combining stable isotope labeling with selective permeabilization 347
Mitochondria in Focus: Targeting the Cell-Death Mechanism 332
Transcriptional profiling of immortalized and K-ras-transformed mouse fibroblasts upon PKA stimulation by forskolin in low glucose availability 320
RAS and PKA pathways in cancer: new insight from transcriptional analysis 317
Oncogenic K-Ras decouples glucose and glutamine metabolism to support cancer cell growth 306
Ras-dependent carbon metabolism and transformation in mouse fibroblasts 294
Cancer cell growth and survival as a system-level property sustained by enhanced glycolysis and mitochondrial metabolic remodeling 288
Expression of transforming K-Ras oncogene affects mitochondrial function and morphology in mouse fibroblasts 285
The Role of Mitochondria in the Chemoresistance of Pancreatic Cancer Cells 278
Suppression of the HBP Function Increases Pancreatic Cancer Cell Sensitivity to a Pan-RAS Inhibitor 273
New Insights into the Connection between Histone Deacetylases, Cell Metabolism, and Cancer 266
Metabolic reprogramming and dysregulated metabolism: Cause, consequence and/or enabler of environmental carcinogenesis? 266
ALDOC- and ENO2- driven glucose metabolism sustains 3D tumor spheroids growth regardless of nutrient environmental conditions: a multi-omics analysis 265
Assessing the carcinogenic potential of low-dose exposures to chemical mixtures in the environment: The challenge ahead 265
Energy metabolism characterization of a novel cancer stem cell-like line 3AB-OS 262
Glucose starvation induces cell death in K-ras-transformed cells by interfering with the hexosamine biosynthesis pathway and activating the unfolded protein response 260
Data recovery and integration from public databases uncovers transformation-specific transcriptional downregulation of cAMP-PKA pathway-encoding genes 255
Integrative transcriptional analysis between human and mouse cancer cells provides a common set of transformation associated genes 254
Glutamine deprivation induces abortive S-phase rescued by deoxyribonucleotides in K-ras transformed fibroblasts 245
Oncogenic K-ras expression is associated with derangement of the cAMP/PKA pathway and forskolin-reversible alterations of mitochondrial dynamics and respiration 242
Acquired glucose sensitivity of k-ras transformed fibroblasts 239
Systems biology and the molecular circuits of cancer 237
Cancer Metabolism as a New Real Target in Tumor Therapy 236
Genetic and Molecular Characterization of The Human Osteosarcoma 3AB-OS Cancer Stem Cell Line: A Possible Model For Studying Osteosarcoma Origin and Stemness 234
Targeting the Unfolded Protein Response for Breast and Pancreatic Cancer Therapy 232
Mitochondrial Complex I inhibitors and forced oxidative phosphorylation synergize in inducing cancer cell death 228
The Association between Vitamin D and Gut Microbiota: A Systematic Review of Human Studies 226
Towards a systems biology approach to mammalian cell cycle: modeling the entrance into S phase of quiescent fibroblasts after serum stimulation 223
Redox-Mediated Suberoylanilide Hydroxamic Acid Sensitivity in Breast Cancer 220
PKA stimulation protects K-ras transformed cells from apoptosis induced by glucose depletion reactivating mitochondrial function 213
Mitochondrial Complex I decrease is responsible for bioenergetic dysfunction in K-ras transformed cells 212
PGC1α/β Expression Predicts Therapeutic Response to Oxidative Phosphorylation Inhibition in Ovarian Cancer 209
Oncogenic K-Ras decouples glucose and glutamine metabolism to support cancer cell growth 208
PGM3 inhibition Shows cooperative Effects With Erastin inducing Pancreatic cancer cell death via activation of the Unfolded Protein Response 205
Vitamin D supplementation and cancer mortality: Narrative review of observational studies and clinical trials 196
Chiral trimethyl lock based on vicinal disubstituent effect: prolonged release of Camptothecin into cancer cells 193
Vitamin D and SARS-CoV2 infection, severity and mortality: A systematic review and meta-analysis 177
Glucose shortage dependent apoptosis in transformed cells upon activation of UPR-autophagy pathway 177
Multi-pathway blood biomarkers to target and monitor multidimensional prevention of cognitive and functional decline (nested in the IN-TeMPO study framed within the world-wide FINGERS network) 169
PGM3 inhibition shows cooperative effects with Erastin inducing pancreatic cancer cell death via activation of the Unfolded Protein Response 167
ALDOC- and ENO2- driven glucose metabolism sustains 3D tumor spheroids growth regardless of nutrient environmental conditions: a multi-omics analysis 146
Moving beyond the Tip of the Iceberg: DJ-1 Implications in Cancer Metabolism 145
Itaconate controls its own synthesis via feedback-inhibition of reverse TCA cycle activity at IDH2 139
Targeting the Unfolded Protein Response for Breast and Pancreatic Cancer Therapy 139
PGM3 insufficiency: a glycosylation disorder causing a notable T cell defect 138
Targeting the Unfolded Protein Response for Breast and Pancreatic Cancer Therapy 128
VITAMIN D SUPPLEMENTATION MAY IMPROVE COVID-19 PROGNOSIS? EVIDENCE FROM A SYSTEMATIC REVIEW AND META-ANALYSIS 126
PO-259 Inhibition of the hexosamine biosynthetic pathway by targeting PGM3 causes breast cancer growth arrest and apoptosis 122
Hexosamine Pathway inhibition: one molecule able to induce a Brcaness phenotype as promising cancer therapy 104
Comparative transcriptional analysis between a K-ras cell model of transformation and the NCI60 human cancer cells collection 100
High throughput metabolomics analysis in normal and K-Ras transformed murine fibroblasts 87
PGM3 Inhibition as a Novel Strategy to Induce BRCAness in HR-Proficient Pancreatic Cancer Cells 79
Hexosamine Biosynthetic Pathway inhibition sensitizes pancreatic cancer cells to DNA damage 77
Inhibition of the Hexosamine Biosynthetic Pathway Enhances Enzalutamide Response in Prostate Cancer Cells 76
PGM3 Inhibition as a Novel Strategy to Induce BRCAness in HR-Proficient Pancreatic Cancer Cells 68
Hexosamine Biosynthetic Pathway inhibition cooperates with gemcitabine inducing in vitro and in vivo pancreatic cancer regression by enhancing DNA damage 68
Targeting the Hexosamine Biosynthetic Pathway with a novel PGM3 inhibitor, FR054, to suppress tumour growth and enhance chemotherapy sensitivity in cancer 57
Targeting Hexosamine Biosynthetic Pathway to Overcome Resistance in Pancreatic Cancer Treatment 55
Exploiting DNA damage response protein O-glycosylation to enhance chemotherapy in pancreatic cancer. 45
PGM3 inhibition shows cooperative effects with erastin inducing pancreatic cancer cell death via activation of the unfolded protein response 44
PGM3 insufficiency: a glycosylation disorder causing a notable T cell defect 44
Exploiting DNA damage protein O-glycosylation to enhance chemotherapy in pancreatic cancer 43
Targeting Hexosamine Biosynthetic Pathway to Overcome Resistance in Pancreatic Cancer Treatment 42
PGM3 inhibition shows cooperative effects with erastin inducing pancreatic cancer cell death via activation of the unfolded protein response 41
Hexosamine biosynthetic pathway inhibition cooperates with gemcitabine inducing in vitro and in vivo pancreatic cancer regression by enhancing DNA damage 30
Inhibition of HBP by targeting PGM3 enzyme as new anticancer therapy 28
Histone glycation: a novel epigenetic target in breast cancer 23
null 3
Totale 16.091
Categoria #
all - tutte 47.589
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 47.589


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021905 0 0 0 0 0 94 95 112 122 154 125 203
2021/20221.055 107 94 124 110 87 91 59 43 53 43 101 143
2022/20231.440 157 403 162 156 104 183 11 78 102 6 59 19
2023/2024975 24 38 27 79 100 217 203 44 65 34 23 121
2024/20253.104 176 254 296 141 214 140 255 156 265 447 307 453
2025/20264.219 737 467 770 940 1.139 166 0 0 0 0 0 0
Totale 16.091